Status:
UNKNOWN
Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation
Lead Sponsor:
University Health Network, Toronto
Conditions:
Liver Transplant Failure
Eligibility:
All Genders
18+ years
Brief Summary
Factor V is a coagulation cofactor that is primarily produced by the liver. Previous data has suggested a correlation between factor V levels and graft dysfunction. The investigators hypothesize that ...
Detailed Description
There is no widely accepted biomarker to assess hepatic function after Liver Transplantation (LT). Factor V is a coagulation cofactor that is primarily produced by the liver. Factor V has a short half...
Eligibility Criteria
Inclusion
- Listed for a deceased donor liver transplant at University Health Network
- Able and willing to provide informed consent
Exclusion
- Patients unable to provide informed consent
- Recipients of live donor liver transplantation
- Re-transplants
- Recipients of multiple organs
Key Trial Info
Start Date :
April 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03396016
Start Date
April 18 2018
End Date
February 28 2023
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital (University Health Network)
Toronto, Ontario, Canada, M5G 2N2